Landos Biopharma Inc. Made Headway
Fri, May 26, 2023 at 07:51 PM
Landos Biopharma Inc. (LABP:NASDAQ) shot up at $2.89, representing a gain of 832%. On Fri, May 26, 2023, LABP:NASDAQ hit a New 2-Week High of $2.89. The stock got featured on our News Catalysts scanner on Thu, May 25, 2023 at 04:40 PM in the 'SPLIT' category. From Fri, May 12, 2023, the stock recorded 50.00% Up Days and 54.55% Green Days
About Landos Biopharma Inc. (LABP:NASDAQ)
Landos Biopharma Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of oral therapeutics for patients with autoimmune diseases.
Top 10 Gainers:
- Landos Biopharma Inc. (LABP:NASDAQ), 831.96%
- Verastem, Inc. (VSTM:NASDAQ), 125.55%
- Elevation Oncology Inc. (ELEV:NASDAQ), 66.78%
- Presto Automation Inc Com (PRST:NASDAQ), 63.93%
- Appreciate Holdings Inc Cl A (SFR:NASDAQ), 59.62%
- Bright Health Group Inc. (BHG:NYSE), 45.85%
- Alarum Technologies Ltd Sponsored ADR (ALAR:NASDAQ), 44.5%
- Peraso Inc. (PRSO:NASDAQ), 40.82%
- Annexon Inc. (ANNX:NASDAQ), 35.71%
- Rigetti Computing Inc. (RGTI:NASDAQ), 34.25%